Tumour progression and spread are influenced by a variety of factors. These include communication between cells, the presence of differing types of cellular lineage in a cancer (tumour heterogeneity) ...
A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian cancer, highlighting that although most biomarkers show little heterogeneity, ...
Not all tumour cells the same Tumours aren't made up of just one cell type – they're a mix of different cells that grow and respond to treatment in different ways. This diversity, or heterogeneity, ...
Visualization in the UMAP space of samples corresponding to the subtypes ER+ (a), HER2+ (b), and TN (c). The samples were categorized by cancer subtype and integrated. Cells are color-coded according ...
A novel co-culture system to validate results of a phase I trial testing new treatment for Barrett’s esophagus. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature two ...
BioWorld - Wednesday, June 11, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » Heterogeneous distribution of ...
Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of protein kinase B inhibition in triple negative breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results